Tag: biosimilars

Manufacturing Challenges for Biosimilars: Complex Production

Manufacturing Challenges for Biosimilars: Complex Production

Manufacturing biosimilars is far more complex than making generics. These living medicines require precise control over cell cultures, glycosylation, and scale-up to match the original biologic-without access to the original recipe.

Read More
How to Reduce Costs for Specialty Medications and Injectables

How to Reduce Costs for Specialty Medications and Injectables

Specialty medications cost thousands per month, but smart strategies like biosimilars, narrow pharmacy networks, and home administration can slash expenses. Learn how employers and patients are saving thousands without losing care.

Read More
Biologic Drugs: Why They Can't Be Copied Like Regular Pills

Biologic Drugs: Why They Can't Be Copied Like Regular Pills

Biologic drugs are made from living cells, making them too complex to copy exactly. Unlike generics, biosimilars are highly similar but not identical, requiring years of testing and expensive manufacturing. Here's why they can't be replicated like regular pills.

Read More